Bioventus Inc. (BVS) stock declined over -1.78%, trading at $10.49 on NASDAQ, down from the previous close of $10.68. The stock opened at $10.35, fluctuating between $10.35 and $10.79 in the recent session.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Employees | 1030 |
Beta | 0.88 |
Sales or Revenue | $512.35M |
5Y Sales Change% | 0.425% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Bioventus Inc. (NASDAQ: BVS) stock price is $10.49 in the last trading session. During the trading session, BVS stock reached the peak price of $10.79 while $10.35 was the lowest point it dropped to. The percentage change in BVS stock occurred in the recent session was -1.78% while the dollar amount for the price change in BVS stock was -$0.19.
The NASDAQ listed BVS is part of Medical - Devices industry that operates in the broader Healthcare sector. Bioventus Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Anthony D'Adamio
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. Katrina J. Church
Senior Vice President & Chief Compliance Officer
Mr. Anthony James
Vice President of Operations and Quality
Ms. Helen Leupold
Senior Vice President & Chief HR Officer
Mr. Mark Singleton
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Ms. Katrina J. Church J.D.
Senior Vice President & Chief Compliance Officer
Mr. Mark L. Singleton
Senior Vice President & Chief Financial Officer
Mr. Jeff Welch
Vice President of Bus. Devel.
Mr. Larry Chen
Managing Director of China & Asia Pacific
Mr. Kenneth M. Reali
Chief Executive Officer & Director
Mr. Leigh Ann Stradford
Senior Vice President & Chief HR Officer
Dr. Peter J. Shaw M.D.
Vice President of Medical Affairs & Chief Medical Officer
Mr. Miguel O. Beltran-Delgado
Senior Vice President of Operations
Ms. Alessandraa Pavesio
Senior Vice President & Chief Science Officer
Mr. Christopher K. Yamamoto
Senior Vice President of Corporation Devel. & Strategy
Ms. Sharon W. Klugewicz
Senior Vice President of Quality & Regulatory Affairs
Mr. Anthony P. Bihl III
Interim Chief Executive Officer & Director
BVS's closing price is 173.85% higher than its 52-week low of $3.90 where as its distance from 52-week high of $14.38 is -25.73%.
Number of BVS employees currently stands at 1,030.
Official Website of BVS is: https://www.bioventus.com
BVS could be contacted at phone 919 474 6700 and can also be accessed through its website. BVS operates from 4721 Emperor Boulevard, Durham, NC 27703, United States.
BVS stock volume for the day was 131.45K shares. The average number of BVS shares traded daily for last 3 months was 373.42K.
The market value of BVS currently stands at $685.71M with its latest stock price at $10.49 and 65.37M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com